Market Research Logo

Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review

Amgen Inc (AMGN) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to treat patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products by using advanced human genetics to unravel the difficulties of disease and understand the fundamentals of human biology. Amgen sells its products primarily to pharmaceutical wholesale distributors in the US. It also markets certain products directly to consumers by direct-to-consumer channels. Amgen is headquartered in Thousand Oaks, California, the US.

Amgen Inc Key Recent Developments

Mar 12,2019 Amgen and Jay Leno Partner to Sound the Alarm on High Cholesterol and its Link to Heart Attack and Stroke in Patients Most at Risk
Mar 11,2019 GE Healthcare announces digital collaboration with Amgen to improve biomanufacturing performance reliability
Feb 19,2019 Amgen Supports Science from Scientists’ Mission to Boost Interest in STEM Education

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Amgen Inc - Key Facts
Amgen Inc - Key Employees
Amgen Inc - Key Employee Biographies
Amgen Inc - Major Products and Services
Amgen Inc - History
Amgen Inc - Company Statement
Amgen Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 - Company Analysis
Company Overview
Amgen Inc - Business Description
Business Segment: Human Therapeutics
Overview
Performance
Key Stats
Business Segment: Other Revenues
Performance
Business Segment: Other Segment
Overview
Geographical Segment: Rest of the world (ROW)
Performance
Geographical Segment: United States
Performance
R&D Overview
Amgen Inc - Corporate Strategy
Amgen Inc - SWOT Analysis
SWOT Analysis - Overview
Amgen Inc - Strengths
Amgen Inc - Weaknesses
Amgen Inc - Opportunities
Amgen Inc - Threats
Amgen Inc - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Amgen Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
Mar 12, 2019: Amgen and Jay Leno Partner to Sound the Alarm on High Cholesterol and its Link to Heart Attack and Stroke in Patients Most at Risk
Mar 11, 2019: GE Healthcare announces digital collaboration with Amgen to improve biomanufacturing performance reliability
Feb 19, 2019: Amgen Supports Science from Scientists’ Mission to Boost Interest in STEM Education
Feb 13, 2019: Abilita and Amgen tie-up targets complex membrane proteins
Jan 29, 2019: Amgen reports fourth quarter and full year 2018 financial results
Jan 24, 2019: Amgen And Allergan Announce Positive TopLine Results From Phase 1 Phase 3 Study Of ABP 798 Biosimilar Candidate To Rituximab
Jan 17, 2019: Premier Enhances Research Offerings, Partners with Leading Life Sciences Companies
Jan 14, 2019: Genscript launches novel technology licensed from Amgen for accelerating protein and antibody purification
Jan 08, 2019: FDA Panel Backs Amgen Bone Drug, Says Benefits Outweigh Heart Risks
Section 6 - Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Amgen Inc, Key Facts
Amgen Inc, Key Employees
Amgen Inc, Key Employee Biographies
Amgen Inc, Major Products and Services
Amgen Inc, History
Amgen Inc, Other Locations
Amgen Inc, Subsidiaries
Amgen Inc, Joint Venture
Amgen Inc, Key Competitors
Amgen Inc, Ratios based on current share price
Amgen Inc, Annual Ratios
Amgen Inc, Annual Ratios (Cont...1)
Amgen Inc, Annual Ratios (Cont...2)
Amgen Inc, Interim Ratios
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Amgen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Amgen Inc, Performance Chart (2014 - 2018)
Amgen Inc, Ratio Charts
Amgen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Amgen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report